LAKE OSWEGO, Ore., Aug. 23, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, President and CEO, will present a corporate overview at the 2012 Southern California Investor Conference. The presentation will take place on Thursday, August 30, 2012 at 2:00 p.m. PDT at the Marriott Hotel in Newport Beach, CA.

The presentation will be webcast and available on the Company's website at http://investors.galenabiopharma.com/events.cfm.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com.

The Galena Biopharma, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10647

CONTACT: Madeline Hatton
         Toll free: +1 (855) 855-GALE (4253), ext. 109
         info@galenabiopharma.com
         
         or
         
         Remy Bernarda
         IR Sense, LLC
         +1 (415) 203-6386
         remy@irsense.com